Navigation Links
Arcturus Therapeutics, Inc. to Present at the Biotech Showcase 2014
Date:1/7/2014

SAN DIEGO, Jan. 7, 2014 /PRNewswire/ -- Arcturus Therapeutics, Inc., an industry leader in RNA technologies for the treatment of rare orphan diseases, today announced that Joseph E. Payne, President & CEO will be presenting at the Biotech Showcase in San Francisco on Monday, January 13, 2014 at 11:30 a.m. PST, at the Parc 55 Wyndham Union Square Hotel in Track A - Hearst (3rd Floor). The presentation will provide a corporate overview and summarize the key accomplishments of 2013, including:

  • Development of a novel, potent and safe RNA Therapeutics platform called LUNARTM technology – a proprietary lipid-enabled delivery system for RNA medicines including small interfering RNA, messenger RNA, and microRNA oligotherapeutics
  • Ownership of Unlocked Nucleic Acid (UNA) chemistry technology and patent portfolio (32 patents, USPTO granted) enabling the targeting of any gene in the human genome
  • Key milestones achieved: Superior in vivo potency data, excellent safety profile as demonstrated in a multiple-dose rat toxicology study, high encapsulation efficiency of RNA cargo greater than 95%, and GMP-readiness of the drug product manufacturing process.

(Logo: http://photos.prnewswire.com/prnh/20130531/MM24393LOGO)

About Arcturus Therapeutics, Inc.
Founded in 2013 and based in San Diego, Calif., Arcturus Therapeutics is focused on RNA technologies for the treatment of rare diseases and high unmet medical needs. Arcturus has developed of a novel, potent and safe RNA Therapeutics platform called LUNAR TM , a proprietary lipid-enabled delivery system for RNA medicines including small interfering RNA, messenger RNA, and microRNA
'/>"/>

SOURCE Arcturus Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
2. Stemline Therapeutics, Inc. Announces Two Poster Presentations of SL-401 Efficacy Data Against Lymphoid Cancers at the 53rd Annual Meeting of the American Society of Hematology (ASH)
3. Stemline Therapeutics, Inc. to Present at the Oppenheimer 22nd Annual Healthcare Conference
4. Cell Therapeutics, Inc. (CTI) Reports First Quarter Financial Results and Milestones
5. Cell Therapeutics, Inc. (CTI) to Report Second Quarter Financial Results on August 1
6. Cell Therapeutics, Inc. (CTI) to Present at Jefferies 2012 Global Healthcare Conference
7. Stemline Therapeutics, Inc. Announces Presentations of SL-401 Updated Clinical Trial Results in Acute Myeloid Leukemia (AML) and Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) and SL-101 Preclinical Efficacy Data Against Hodgkins Lymphoma at
8. Cell Therapeutics, Inc.s (CTI) Board of Directors Approves Amendment of Shareholder Rights Plan
9. Comprehensive Global Testing Solutions for Novel Hepatitis C Therapeutics, New Webinar Hosted by Xtalks
10. Before the Bell Scans: Pharmacyclics, United Therapeutics, Impax Laboratories, and Star Scientific
11. BioTech Companies in the News - Alliqua, Transition Therapeutics, Organovo, MiMedx Group, Keryx Biopharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Francisco, CA (PRWEB) , ... September 04, 2015 ... ... the delivery of product safety and pharmacovigilance services and software tools to pharmaceutical ... application, PRIMO Mobile by Allergan Japan. PRIMO Mobile is a mobile data intake ...
(Date:9/3/2015)... - bioLytical Laboratories Inc., a leader in rapid diagnostic ... of a rapid point of care assay for early ... HIV gp41 IgM antibodies " has been published in ... ability to detect early HIV infection.  ... annual International AIDS Society Conference, which highlighted early ...
(Date:9/3/2015)... ... September 03, 2015 , ... If you plan to attend the ... October, you will also want to sign up for the tour of Framingham State ... tour includes a walk through of the (8) chemistry teaching labs that are exclusively ...
(Date:9/2/2015)... Research and Markets ... Jain PharmaBiotech,s new report "Biochips and Microarrays ... offering. This report is an analysis ... The report starts with a description of technologies ... include array comparative genomic hybridization (CGH), copy number ...
Breaking Biology Technology:November Research Group’s PRIMO Mobile Goes Live at Allergan Japan 2bioLytical's INSTI HIV Test Detects gp41 specific IgM Antibodies 2bioLytical's INSTI HIV Test Detects gp41 specific IgM Antibodies 3Erlab Invites You to Tour the Largest Installation of Filtered Fume Hoods in the World 2Global Biochips and Microarrays Technologies, Markets and Companies Report 2015 with Market Size in 2014 and Projected Value for the Years 2019 and 2024 2
... SAN RAMON, Calif., Aug. 7 Odyssey Thera, ... from Pfizer Inc, following,Pfizer,s decision to progress a ... candidate was extensively studied by,Odyssey Thera as part ... are very pleased with the progress of the ...
... 7 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics,Inc. (OTC Bulletin Board: CHBT), ... manufacture, marketing and distribution of,probiotics dietary supplements, today ... a.m. EDT on Friday, August 15, 2008, to ... ended June 30, 2008, of its fiscal,2009., ...
... SCOLR Pharma, Inc.,(Amex: DDD ) today reported ... 30, 2008. The Company will host a live conference ... Time)., Daniel O. Wilds, SCOLR Pharma,s President and ... during the second quarter,maintaining a sharp focus on advancing ...
Cached Biology Technology:China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results 2China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results 3SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results 2SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results 3SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results 4SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results 5SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results 6SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results 7
(Date:8/31/2015)... Research and Markets ( http://www.researchandmarkets.com/research/st5b3m/saudi_arabia ) has ... Sensors Market - Growth, Trends & Forecasts (2014-2020)" ... Arabia Biomedical Sensors market is estimated at $0.23 billion ... period 2014-2020 The near future will bring ... of each individual. These sensors can be set to ...
(Date:8/25/2015)... and BELLEVUE, Wash. , Aug. ... advanced robotic systems, announced today it will unveil its ... vehicle (UGV), at the National Tactical Officers Association Conference ... The Guardian S is the first-ever commercially available ... years of research and in-field trials and is protected ...
(Date:8/20/2015)... The wearable technology market has traditionally ... healthy. However, wearable technology has the potential to ... improve diagnostic capabilities and therapeutic outcomes. Today, Leaf ... Technologies Conference 2015 , where Barrett Larson ... healthcare.    "Over the past decade, ...
Breaking Biology News(10 mins):Saudi Arabia Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts (2014-2020) 2Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3
... we thought that gene expression was modulated only by transcription ... could be regulated by the RISC complex (siRNA-mediated degradation via ... level is even more complex than we first imaginated... ... requirement for using a weapon or tool is finding it. ...
... five mammals living on Earth is a bat, yet their ... record and conflicting or incomplete theories about their origins and ... Riverside Biology Professor Mark Springer, has published a paper in ... molecular biology and the fossil data to fill in many ...
... breast cancer treated with radical mastectomy and adjuvant chemotherapy, ... outcomes with few long-term toxic effects, according to a ... the January 19 issue of the Journal of the ... therapy trial was designed to determine the effect on ...
Cached Biology News:A new mechanism of regulating RNA degradation 2A new mechanism of regulating RNA degradation 3Molecular biology fills gaps in knowledge of bat evolution 2Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down 2
... Sciences provides a comprehensive kinase analysis ... substrate (PKS) peptide microarrays synthesized on ... kinase profiling, quantitative measurement of kinase ... This comprehensive service includes preparation of ...
... NH2-terminal kinase) signal transduction cascade is ... pathways in mammals. JNK pathway activation ... is associated with the nuclear accumulation ... in the immune response, cellular proliferation, ...
... ProteomeLab PA 800 is an automated, ... of Beckman Coulters ProteomeLab family of ... comprehensive range of automated protein characterization ... mapping, isoelectric focusing, carbohydrate profiling and ...
... Library Panels were designed for full-length gene ... PCRs to identify the desired cDNA clone. ... a 96-well "Master Plate," where each well ... identified the positive well(s) by gel electrophoresis ...
Biology Products: